Presence of a marked nonneuronal cholinergic system in human colon: Study of normal colon and colon in ulcerative colitis

Inflammatory Bowel Diseases

Volumn 13, Issue 11, 2007, Pages 1347-1356

  Jönsson, Maria ^a   Norrgård, Örjan ^a   Forsgren, Sture ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

ChAT; Cholinergic system; Muscarinic; Ulcerative colitis; VAChT

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; CORTICOSTEROID; MESSENGER RNA; MUSCARINIC M2 RECEPTOR; PREDNISONE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADULT; AGED; ARTICLE; BLOOD VESSEL WALL; CELL STRUCTURE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENDOCRINE CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; INTESTINE MUSCLE; LAMINA PROPRIA; LOW DRUG DOSE; MALE; MYENTERIC PLEXUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; CHOLINE O-ACETYLTRANSFERASE; COLITIS, ULCERATIVE; COLON; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RECEPTOR, MUSCARINIC M2; TISSUE DISTRIBUTION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 36749061943     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20224     Document Type: Article

References (44)

1. Eiden LE. The cholinergic gene locus. J Neurochem. 1998;70:2227-2240.
2. Hellstrom J, Oliveira AL, Meister B, et al. Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2. J Comp Neurol. 2003;460:476-486.
3. Rouse ST, Edmunds SM, Yi H, et al. Localization of M(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci Lett. 2000;284:182-186.
4. Li ZS, Furness JB. Immunohistochemical localization of cholinergic markers in putative intrinsic primary afferent neurons of the guinea-pig intestine. Cell Tissue Res. 1998;294:35-43.
5. Li ZS, Fox-Threlkeld JE, Furness JB. Innervation of intestinal arteries by axons with immunoreactivity for the vesicular acetylcholine transporter (VAChT). J Anat. 1998;192:107-117.
6. Olsson C, Costa M, Brookes SJ. Neurochemical characterization of extrinsic innervation of the guinea pig rectum. J Comp Neurol. 2004;470:357-371.
7. Domeneghini C, Radaelli G, Arrighi S, et al. Cholinergic, nitrergic and peptidergic (Substance P- and CGRP-utilizing) innervation of the horse intestine. A histochemical and immunohistochemical study. Histol Histopathol. 2004;19:357-370.
8. Ratcliffe EM, deSa DJ, Dixon MF, et al. Choline acetyltransferase (ChAT) immunoreactivity in paraffin sections of normal and diseased intestines. J Histochem Cytochem. 1998;46:1223-1231.
9. Schneider J, Jehle EC, Starlinger MJ, et al. Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol Motil. 2001;13:255-264.
10. Porter AJ, Wattchow DA, Brooks SJ, et al. The neurochemical coding and projections of circular muscle motor neurons in the human colon. Gastroenterology. 1997;113:1916-1923.
11. Wessler I, Reinheimer T, Kilbinger H, et al. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci. 2003;72:2169-2172.
12. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther. 2000;86:29-48. Review.
13. Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003;74:675-696.
14. Grando SA, Kist DA, Qi M, et al. Human keratinocytes synthesize, secrete and degrade acetylcholine. J Invest Dermatol. 1993;101:32-36.
15. Kirkpatrick CJ, Bittinger F, Unger RE, et al. The non-neuronal cholinergic system in the endothelium: evidence and possible pathobiological significance. Jpn J Pharmacol. 2001;85:24-28.
16. Wessler I, Kirkpatrick J, Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans. Pharmacol Ther. 1998;77:59-79.
17. Lips KS, Pfeil U, Reiners K, et al. Expression of the high-affinity choline transporter CHT1 in rat and human arteries. J Histochem Cytochem. 2003;51:1645-1654.
18. Klapproth H, Reinheimer T, Metzen J, et al. Non-neuronal acetylcholine, a signaling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:515-523.
19. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290. Review.
20. Yamanishi T, Chapple CR, Yasuda K, et al. The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra. J Urol. 2002;168:308-314.
21. Iino S, Nojyo Y. Muscarinic M2 acetylcholine receptor distribution in the guinea-pig gastrointestinal tract. Neuroscience. 2006;138:649-559.
22. Shanahan F, Anton P. Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease. Dig Dis Sci. 1988;33:41S-49S.
23. Neunlist M, Aubert P, Toquet C, et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut. 2003;52:84-90.
24. Wessler I, Kirkpatrick J. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther. 2001;14:423-434.
25. Czura CJ & Tracey KJ. Autonomic neural regulation of immunity. J Intern Med. 2005;257:156-166.
26. de Jonge W, van der Zanden E, The F, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844-851.
27. Nickel WF Jr, Gordon GM, Andrus WD. Studies on several cholinergic drugs as possible etiologic agents in ulcerative colitis. Gastroenterology. 1953;24:556-559.
28. Hansson, M, Forsgren, S. Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system. Histochem J. 1995;27:222-230.
29. Pals-Rylaarsdam R, Hosey MM. Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the M2 muscarinic acetylcholine receptor. J Biol Chem. 1997;272:14152-14158.
30. Lips KS, Wunsch J, Zargooni S et al. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol. 2007;51:1042-1053.
31. Fritz S, Fohrr KJ, Boddien S, et al. Functional and molecular characterization of a muscarinic receptor type and evidence for expression of choline-acetyltransferase and vesicular acetylcholine transporter in human granulosa-luteal cells. J Clin Endocrinol Metab. 1999;84:1744-1750.
32. Kawashima K, Watanabe N, Oohata H, et al. Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci Lett. 1990;119:156-158.
33. Kirkpatrick CJ, Bittinger F, Nozadze K, et al. Expression and function of the non-neuronal cholinergic ystem in endothelial cells. Life Sci. 2003;72:2111-2116.
34. Enriquez de Salamanca A, Siemasko KF, Diebold Y, et al. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci. 2005;46:504-513.
35. Hirota CL, McKay DM. Cholinergic regulation of epithelial ion transport in the mammalian intestine. Br J Pharmacol. 2006;149:463-479.
36. Mayerhofer A, Fritz S. Ovarian acetylcholine and muscarinic receptors: hints of a novel intrinsic ovarian regulatory system. Microsc Res Tech. 2002;59:503-508.
37. Metzen J, Bittinger F, Kirkpatrick J, et al. Proliferative effect of acetylcholine on rat trachea epithelial cells is mediated by nicotinic receptors and muscarinic receptors of the M1-subtype. Life Sci. 2003;72:2075-2080.
38. Eglen RM. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol. 2006;26:219-233.
39. Tayebati SK, El-Assouad D, Ricci A, et al. Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol. 2002;132:147-155.
40. Staskin DR, MacDiarmid SA. Using anticholinergics to treat overactive bladder: the issue of treatment tolerability. Am J Med. 2006;119:9-15.
41. Chapple CR, Yamanishi T, Chess-Williams R. Muscarinic receptor subtypes and management of the overactive bladder. Urology. 2002;60:82-88.
42. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859. Review.
43. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med. 1983;308:261-263.
44. Ando Y. Transdermal nicotine for ulcerative colitis. Ann Intern Med. 1997;127:491-492.